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404-5 Vascular Endothelial Growth Factor (VEGF) Plays a 
Central Role in the Development of Diabetic 
Cardiomyopathy and Gene Transfer of VEGF Improves 
Heart Failure in Long-Standing Streptozotocin-Induced 
Diabetic Rat
Young-Sup Yoon, Shigeki Uchida, Jong-Seon Park, Cynthia Curry, Jeffrey M. Isner, 
Douglas W. Losordo, St. Eliazabeth's Medical Center, Tufts University School of 
Medicine, Boston, MA
Background: Diabetic cardiomyopathy (DCM), which is characterized by interstitial fibro-
sis and microvascular pathology, progressively leads to heart failure (HF). Using the
streptozotocin-induced diabetic rat model, we evaluated the natural course of DCM over
a period of one year and tested whether VEGF gene transfer could improve diabetic HF.
Methods and Results: Diastolic dysfunction developed in the early phases and pro-
gressed in all rats. Systolic dysfunction developed later and became significant in 24% of
the rats. Downregulation of myocardial VEGF expression was detected early in the
course of DCM, followed by increased apoptosis of endothelial cells (ECs), decreased
numbers of circulating endothelial progenitor cells (EPCs), and finally by decreased cap-
illary density and impaired myocardial perfusion. Ultimately, apoptosis and necrosis of
cardiomyocytes (CMCs) ensued along with fibrosis. Based on this observed sequence of
events, we evaluated a strategy of angiogenic gene therapy (GT) via direct intramyocar-
dial injection of plasmid DNA encoding VEGF(phVEGF165). Rats were randomized to
receive phVEGF165, LacZ plasmid or sham operation (n =14, each group). Only the
VEGF group showed increased capillary density and decreased EC and CMC apoptosis.
Bone marrow (BM) transplantation studies documented evidence for in situ differentiation
of BM derived EPCs into ECs in the VEGF group. These anatomic findings were accom-
panied by significant improvement in cardiac function in the VEGF group alone.
Conclusion: Here, we first demonstrate that down-regulation of VEGF plays a central
role in the pathogenesis of DCM and that replenishment of VEGF, using a direct myocar-
dial GT approach, can improve HF by augmenting neovascularization through angiogen-
esis and vasculogenesis and by reestablishing VEGF homeostasis in the myocardium.
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406-1 Hypoxia Regulatable Aav-2 Vector Protects Against 
Cardiac Ischemia/Reperfusion Injury
Alok S. Pachori, Luis G. Melo, Lunan Zhang, Richard E. Pratt, Victor J. Dzau, Brigham & 
Women's Hospital, Boston, MA, University of Saskatoon, Saskatchwaan, SK, Canada
Purpose: We have previously demonstrated that constitutive overexpression of heme-
oxygenase 1 protects against myocardial injury. The purpose of this study is to test the
efficacy of a hypoxia inducible vector encoding heme oxygenase 1, for protection against
myocardial ischemia and reperfusion injury by determining the inducibility of the vector
during ischemia and protection against ischemia and reperfusion injury.
Methods: Eight week old male Sprague-Dawley (SD) rats were divided into two groups
(n=15-16/group) and injected with either AAV-4HRE-mSV40-HO-1 OR AAV-4HRE-
mSV40-LacZ (4 X 1011 pfu/ml). Four weeks after injection, animals from both groups
were randomized and subjected to either sham surgery or surgery consisting of a 1 hour
ischemia followed by reperfusion for 6, 12 and 24 hours. Following reperfusion, tissues
were harvested and used for protein and RNA isolation and TTC staining for determina-
tion of infarct size. Separate group of animals were used for echocardiographic analysis
of cardiac function following I/R injury.
Results: Our results indicate that compared to baseline, ischemia/reperfusion injury
resulted in a significant increase in HO-1 protein and activity levels in HO-1 transduced
animals. More importantly, there was a significant decrease in the infarct size in HO-1
treated animals versus the control group (31.0 ± 5.58 vs. 12.1 ± 2.15, p<.01) as well as
complete improvement in cardiac function parameters such as ejection fraction, septal
and posterior wall thickness and LV volume and area, one month after injury, as deter-
mined by echocardiographic analyses.
Conclusion: In this study we have demonstrated that expression of exogenous hHO-1
can be regulated by hypoxia developed during global ischemia. The data indicate that
overexpression of hHO-1 during ischemia and early reperfusion has a marked protective
effect on the myocardium. This is the first evidence of the therapeutic efficacy of inducible
expression and provides proof-of-concept for the feasibility of this approach for protection
against ischemia/reperfusion injury. 
11:15 a.m.
406-2 Stem Cell Factor Plays a Critical Role in Neointimal 
Formation by Bone Marrow Derived Progenitor Cells
Subodh Verma, Chao-Hung Wang, William Stanford, Richard D. Weisel, University of 
Toronto, Toronto, Canada
We hypothesized that stem cell factor (SCF) is a critical mediator of restenosis facilitating
mobilization, homing & transdifferentiation of progenitors. Femoral injury was induced in
wildtype, WBB6F1 (W/WV) (c-kit deficient) & WCB6F1 (Sl/Sld, Steel-Dickie) (mSCF defi-
cient) mice & neointimal formation, SCF, c-kit, SMA & MMP-9 quantified. Progenitor cell
mobilization was evaluated by circulating SCF levels & CD34+ cells. Vascular injury fol-
lowing BM transplantation using donor cells expressing eYFP (BMTYfp→Wild) was per-
formed. The effects of SCF & SMCs on Lin- BM cell adhesion to fibronectin was studied
in addition to coculture of eYFP+ Lin- BM cells with activated SMC. The effects of PDGF
& A-II on SCF expression following vascular injury were evaluated, as were the effects of
long-term ACEI. W/Wv & Steel-Dickie mice exhibited marked attenuation in neointimal
formation at day 14 & 28 (P<0.001) In wild-type mice vascular injury resulted in the eleva-
tion of sSCF compared to Steel-Dickie mice & induced an increase in circulating CD34+
progenitors (P<0.01). An increase in SCF, proMMP-9 & MMP-9 expression in the adven-
titia occurred within the first week following vascular injury. BMTYfp→Wild indicated the
presence of c-kit positive cells within the medial layer expressing SMA. SCF induced a
marked increase in adhesion of BM cells to fibronectin suggesting a direct role of SCF in
progenitor recruitment (P<0.001). Activated rat SMCs increased the adhesion of BM cells
& coculture of eYFP Lin- BM cells with SMC showed clusters of cells expressing both
eYFP & SMA, suggesting that SMC activation, marked by SCF expression, is required for
progenitor differentiation. PDGF & A-II upregulated SMCc SCF expression in a dose
dependent fashion, & ACEI (BMTYfp→Wild) suppressed the number of BM derived neoint-
imal cells(P<0.01). In conclusion, vascular injury upregulates local mSCF expression &
activates MMP-9, facilitating the shedding of sSCF with resultant mobilization and hom-
ing of BM progenitors to sites of vascular injury. In-vivo deficiency of SCF or its receptor,
c-kit is associated with reduced neointimal formation. Targeting SCF may serve as a
novel therapeutic strategy for restenosis.
11:30 a.m.
406-3 Protecting Ischemic Hearts With a Hypoxia-Sensitive 
Heme Oxygenase-1 Plasmid System
Yao Liang Tang, Yi Tang, Y. Clare Zhang, Keping Qian, M. Ian Phillips, All Children 
Hospital, Children Research Institute, St. Petersburg, FL, Stanford University, Stanford, 
CA
Background: Although human heme oxygenase-1(hHO-1) could provide a useful
approach for cellular protection in the ischemic heart, constitutive over-expression of
hHO-1 may lead to unwanted side effects. We designed a hypoxia-regulated hHO-1 gene
therapy system named vigilant hHO-1 plasmid system, which is based on an oxygen
dependent degradation domain (ODD) from the hypoxia inducible factor-1-alpha (HIF-1α)
that can sense ischemia and switch on hHO-1 gene in the heart.
Methods and Results: In in vitro experiment, HEK293 cells were transfected with vigi-
lant hHO-1 plasmid, it produced a robust hHO-1 induction upon exposure to low oxygen.
In a mouse model for myocardial infarction, the vigilant hHO-1 plasmids turned on hHO-1
genes specifically to ischemic myocardium. At 10 days after gene transfer, Masson
trichrome staining showed significantly fewer fibrotic aeas in vigilant hHO-1 plasmids
treated mice compared with saline control (43.0±4.8% vs 62.5±3.3%, P<0.01), the reduc-
tion of interstitial fibrosis is accompanied by an increase in myocardial hHO-1 expression
in peri-infarct border areas, concomitant with reduced apoptosis in the ischemic myocar-
dium compared to saline control. By use of a cardiac catheter in close-chest preparation,
heart from vigilant hHO-1 plasmids treated mice showed improved recovery of contractile
and diastolic performance after MI compared with saline control.
Conclusions: This study documents the beneficial regulation and therapeutic effect of
vigilant plasmid-mediated hHO-1 gene transfer. This novel prophylaxis gene transfer
strategy can provide cardiac specific protection from future repeated bouts of ischemic
injury.
11:45 a.m.
406-4 Mice Lacking the Transcription Factor CHF1/Hey2 Show 
Decreased Arterial Neointimal Formation After Injury 
and Impaired Vascular Smooth Muscle Cell 
Responsiveness to Growth Factors
Yasuhiko Sakata, Fan Xiang, Zhiping Chen, Yoriko Kiriyama, Caramai N. Kamei, Daniel I. 
Simon, Michael T. Chin, Brigham & Women's Hospital, Cambridge, MA
Background: The hairy-related bHLH transcription factor, CHF1/Hey2, has been shown
to play an important role in zebrafish vascular development, however, no anatomical
defects in the vascular system have been reported in CHF1/Hey2-deficient mice. Meth-
ods: We investigated the functional vascular phenotype of CHF1/Hey2-deficient mice by
measuring vascular remodeling after injury in vivo and primary cultured vascular smooth
muscle cell (VSMC) function in vitro. Results: Neointima formation after arterial wire
injury was markedly decreased in KO compared to WT mice (0.025+0.011 mm2 in WT
(n=13) vs. 0.016+0.008 mm2 in KO (n=12), p<0.05). Analysis of primary cultured VSMCs
revealed that CHF1/Hey2 deficient VSMCs proliferate comparably to WT VSMCs but
showed decreased migration in response to platelet derived growth factor (PDGF)
(62.6+10.3/CPF vs. 37.2+13.5/CPF, p<0.01) and heparin-binding epidermal growth fac-
tor-like growth factor (HB-EGF)(27.4+7.7/CPF vs. 6.4+3.7/CPF, p<0.05) as assessed by
modified Boyden chamber assay. Further, PDGF and HB-EGF induced diminished
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cytoskeleton reorganization and cell shape changes in terms of lamellipodia formation in
KO VSMCs compared with WT VSMCs.
Conclusions: These findings suggest that CHF1/Hey2 is an important
regulator of VSMC motility during vascular remodeling through control of PDGF and HB-
EGF dependent signaling pathways.
Noon
406-5 Oxidized Low-Density Lipoprotein-Stimulated Smooth 
Muscle Cell Growth Is Mediated by the Helix Loop Helix 
Factor Id3: A Novel Mechanism Contributing to 
Atherosclerotic Lesion Formation
Angela M. Taylor, Feng Li, Ross Gerrity, Richard L. Birnbaum, Martin Matsumura, Sarah 
Rutherford, Puspha-Rekha Thimmalapura, Coleen A. McNamara, University of Virginia, 
Charlottesville, VA
Background: Oxidation of LDL has emerged as the initiating event in cardiovascular
lesion formation. Little is known about the molecular mechanisms linking Ox-LDL and
vascular smooth muscle cell accumulation, the harbinger of vascular lesion progression.
The HLH transcription factor Id3 is a redox sensitive gene that is expressed in VSMC in
response to mitogen stimulation and vascular injury. Id3 is a regulator of growth and dif-
ferentiation in several other cell types. Accordingly we hypothesize that Id3 is an impor-
tant mediator of Ox-LDL-induced VSMC growth.
Methods: Primary vascular smooth muscle cells were infected with AdId3 or AdGFP
control and assayed for cell number, BrdU incorporation and p21cip1 expression by West-
ern blot analysis. Parallel cultures were stimulated with Ox-LDL or nLDL or sera from
hyperlipemic, atherosclerotic pigs or normolipemic pigs without vascular lesions.
Results: Results demonstrated that increasing Id3 expression in VSMC decreased
p21cip1 expression and increased BrdU incorporation and cell number. Cotransfection
with pAdId3 and p21cip1 promoter-luciferase reporter construct demonstrated that Id3
regulates p21cip1 promoter activation in VSMC. Ox-LDL and hyperlipemic porcine sera
increase Id3 protein expression and VSMC proliferation. Consistent with the role of Id3
as an inhibitor of p21cip1 expression, infection with pAdId3 increased BrdU incorporation
and increased cell number. Stimulation with hyperlipemic sera increased cell number and
S-phase entry. Furthermore, aortas of hyperlipemic pigs demonstrated significantly more
Id3 than normolipemic controls.
Conclusion: The HLH factor Id3 mediates the mitogenic effect of hyperlipemic sera and
Ox-LDL in VSMC via inhibition of p21cip1 expression and inhibition of DNA synthesis.
Moreover, hyperlipemic, atherosclerotic animals express greater amounts of Id3 protein
in the vessel wall than normolipemic controls providing the first in vivo evidence implicat-
ing Id3 as an important mediator of atherogeneis.
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408-1 Genetic Polymorphism G894T on Endothelial Nitric 
Oxide Synthase Gene as a Risk Factor for Premature, 
Nonfatal Myocardial Infarction in Young Male Smokers
Charalambos Antoniades, Dimitris Tousoulis, Christos Pitsavos, Carmen Vasiliadou, 
Christina Chrysochoou, Marina Toutouza, Demosthenis Panagiotakos, Costas 
Tentolouris, Pavlos Toutouzas, Christodoulos Stefanadis, Athens University Medical 
School, Cardiology Department, Hippokration Hospital, Athens, Greece
Background. Endothelial nitric oxide synthase (eNOS) gene polymorphism G894T has
been associated with arterial hypertension and myocardial infarction (MI) in older ages.
However, its role in the pathogenesis of premature MI remains unclear. We investigated
whether this polymorphism is associated with premature non-fatal MI.
Methods. This case-control study enrolled 212 young patients with premature non-fatal
MI (aged 46.5±5.2 years old) and 577 healthy age- matched controls (aged 48.1±13.5
years old), derived from ATTICA cohort. Polymerase chain reaction was done to detect
G894T polymorphism on the eNOS gene. X2 was used to test the significance of an
association between eNOS genotype and the presence of premature MI (under the age
of 50).
Results. Homozygosity for the 894T allele, existed in 27 MI patients (13%) and in 58
(10.1%) controls (p=0.281). The frequency of T allele was 0.552 among cases and 0.518
among controls (p= 0.126). In comparison to 894G homozygotes, the odds ratio for MI
was 1.406(95%CI: 0.843 to 2.347, p= 0.191) for 894T homozygotes and 1.172 (95%CI:
0.837 to 1.64, p=0.355) for heterozygotes respectively. However, among male smokers,
homozygosity for this polymorphism was observed in 23 of 179 MI cases (12.8%) and
only in 7 of 157 controls (4.5%) (p=0.008). Among male smokers, the odds ratio for MI in
TT homozygotes was 3.367 (95%CI: 1.369 to 8.279, p= 0.006) compared to GG, 2.935
(95%CI: 1.184-7.277, p=0.017) compared to GT and 3.159 (95%CI:1.317-7.581,
p=0.007) compared to GG+GT. However, no association between G894T polymorphism
and premature MI was observed in male non-smokers and in female smokers or non-
smokers.
Conclusions. The present study supports that G894T polymorphism on eNOS gene
may interact with smoking leading to premature, non-fatal myocardial infarction in young
males.
2:15 p.m.
408-2 Cardiac Troponin Elevations in Marathon Runners: 
Prevalence and Risk Factors
Elizabeth B. Fortescue, Andrew Y. Shin, David S. Greenes, Rebekah Mannix, Nader 
Rifai, Michael J. Landzberg, Jane W. Newburger, Christopher SD Almond, Children's 
Hospital Boston, Boston, MA, Harvard Medical School, Boston, MA
Background: Elevations in serum cardiac troponins have been found to occur in runners
completing long distances.Our objectives were to determine prevalence of and risk fac-
tors for troponin elevations in marathon finishers.
Methods: Entrants in the 2002 Boston Marathon were recruited the weekend prior to the
race, at which time we obtained demographic, health history, and training data. At race
completion, we obtained race performance data and serum third-generation troponin T
(cTnT) and I (cTnI) levels. Potential risk factors for troponin elevations were selected a
priori from clinical suspicion and literature review and were evaluated using logistic
regression analysis.
Results: A total of 482 runners completed surveys and had labs drawn. In all, 33% were
female, 20% were aged <30 years, and 92% had run at least one prior marathon. Com-
pared to males, females were significantly younger (p<0.001), slower (p<0.001), and less
experienced marathoners (p=0.018). The majority of marathon runners in our cohort
(68%) had some degree of troponin elevation after completing the marathon (cTnT>0.01
ng/mL or cTnI>0.1 ng/mL); of these, 55 (17%) had significant elevations (cTnT >0.075
ng/mL or cTnI>0.5 ng/mL). On multivariate analysis, individuals at greatest risk of signifi-
cant troponin elevations were less experienced marathoners (<5 prior marathons run,
O.R. 3.3, 95% C.I. 1.6-6.6, p<0.001) and younger runners (<30 years, O.R. 2.4, 95% C.I.
1.3-4.5 p=0.006). Female gender was a univariate but not multivariate correlate, and
health history, anthropometrics, family history, training intensity, and race performance
were not associated. Young age and marathon inexperience were robust predictors of
troponin elevations over a broad range of threshold values analyzed and with troponins
evaluated as continuous variables.
Conclusion: In a large and athletically diverse group of marathon finishers, we found that
significant troponin elevations were common, and that less experienced marathoners and
younger runners were at greatest risk of experiencing elevations. Further prospective
research by our group into potential clinical significance of these findings is ongoing.
2:30 p.m.
408-3 Quantitative Detection of Inflammation in Carotid 
Atherosclerosis by Dynamic Contrast Enhanced 
Magnetic Resonance Imaging
William S. Kerwin, Marina Ferguson, Kevin O'Brien, Thomas Hatsukami, Chun Yuan, 
University of Washington, Seattle, WA
Background: Inflammation in advanced atherosclerotic plaque is a primary catalyst for
disruption of the plaque and subsequent thromboembolic events. Thus, a quantitative,
non-invasive technique for characterizing inflammation would be invaluable for detecting
vulnerable, inflamed plaques and monitoring therapeutic response. We hypothesize that
the dynamic response of magnetic resonance imaging (MRI) to an injected gadolinium
contrast agent can be used for quantitative evaluation of inflammation by measuring the
transfer constant Ktrans between the blood plasma and the extracellular space. This
parameter is derived from the curve of enhancement vs. time and quantifies the
increased vascularity, permeability, and extracellular water content associated with the
inflammatory response.
Methods: The association of Ktrans with macrophages, the predominant inflammatory
cells in human carotid atherosclerotic plaque, was evaluated in 18 carotid endarterec-
tomy patients. Within one week prior to surgery, cross-sectional MRI scans centered at
the carotid bifurcation of each patient were performed using a dynamic protocol (fast
spoiled gradient echo; 15 seconds per image; 10 time frames), which included injection
of 0.1 mmol/kg of a standard, low molecular weight gadolinium contrast agent. Kinetic
modelling of the MRI results was used to estimate Ktrans and the fractional plasma vol-
ume vp of the plaque. After surgery, the endarterectomy specimens were sectioned,
matched to the MRI results, and double-stained for macrophages (HAM56) and vascular
endothelial cells (Ulex, to mask cross-labelling by HAM56). The relative area of each
specimen staining positive for macrophages was measured and normalized by the total
plaque area.
Results: Macrophage content of the excised specimens was found to correlate strongly
with Ktrans (R= 0.74, p=0.0005) as measured by MRI.
Conclusion: Ktrans serves as a powerful marker of inflammation for clinical evaluation of
atherosclerotic plaque. The strong correlation suggests it can be used to measure thera-
peutic response aimed at reducing plaque inflammation.
